ProPhase Labs Inc. (DE) (PRPH) Financials

$0.02

$0.00 (-3.81%)

As on 02-Sep-2026 15:43EDT

Market cap

$0 Mln

Revenue (TTM)

$3 Mln

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	3.16	4.35	6.77	44.38	122.65	79.04
Cost of Revenue	2.64	2.96	6.92	28.15	51.99	46.23
Gross Profit	0.52	1.38	-0.15	16.24	70.65	32.81
Operating Expenses	16.79	19.43	38.48	37.85	47.06	23.01
Operating Profit (EBIT)	-15.74	-18.05	-38.63	-21.61	23.60	9.80
Other Income	--	--	--	--	--	--
Profit before Tax	-22.04	-23.39	-42.33	-22.40	22.91	5.31
Provision for Tax	1.23	-8.64	7.20	-6.02	4.45	-0.97
Profit after Tax (Net Income)	-22.64	-14.74	-53.36	-16.78	18.46	6.27
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	6.27

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-3.11	3.51	7.35	49.38	63.63	58.63
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	2.43	3.28	23.71	21.69	7.94	15.14
Current Liabilities	58.09	53.08	32.13	20.86	16.08	15.52
Total Liabilities	115.50	59.87	63.20	91.93	87.65	89.30

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	54.61	56.72	32.56	44.34	26.81	27.98
Current Assets	2.80	3.15	30.64	47.59	60.83	61.32
Total Assets	60.21	59.87	63.20	91.93	87.65	89.30
Total Debt*	9.12	8.62	24.57	18.46	6.96	14.90
Net Current Assets	--	-49.93	-1.50	26.73	44.76	45.79

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-8.34	-17.54	-11.35	28.55	-13.62
Cash Flow from Investing Activities	--	0.92	2.42	-1.37	-2.08	-19.67
Cash from Financing Activities	--	6.84	14.19	5.76	-26.02	35.13
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-3.12	-1.64	-1.79	-9.30	11.39	4.06
Cash EPS ($)	--	-1.08	-1.56	-6.10	14.51	6.37
Adjusted Book Value ($)	--	0.39	0.25	27.37	39.25	37.97
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.93	-0.59	-6.29	17.61	-8.82
Free Cash Flow per Share ($)	--	-0.93	-0.62	-8.04	15.19	-11.56

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-66.93	-106.98	-24.25	25.62	12.70
ROE (%)	--	-271.49	-188.11	-29.70	30.20	18.13
ROA (%)	-35.41	-23.96	-68.80	-18.69	20.87	10.39
EBIT Margin (%)	-361.88	-378.69	-575.78	-48.50	19.30	8.16
Net Margin (%)	-717.43	-339.31	-788.24	-37.81	15.05	7.94
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-5.51	-0.36	-0.85	-0.64	0.55	4.45
EBIT Growth (%)	33.13	57.79	-81.09	-190.93	266.84	419.61
Net Profit Growth (%)	45.38	72.37	-217.98	-190.90	194.32	395.20
EPS Growth (%)	13.24	0.08	0.81	-1.82	1.80	3.22
Book Value Growth (%)	-108.06	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.27	-0.42	-0.49	0.85	1.76
Price / Book Value	0.37	1.14	3.08	0.17	0.25	0.19
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	2.45	-1.10	-1.44	-1.48	0.18	0.74
Close Price ($)	0.10	0.45	7.57	45.20	96.30	71.70
High Price ($)	6.66	9.35	74.80	99.41	152.50	160.40
Low Price ($)	--	0.41	6.11	40.50	62.00	44.10
Market Cap ($ Cr)	0.31	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	2.46	3.34	0.37	0.11	0.25
Short term debt to equity ratio	-2.90	2.27	0.89	0.06	0.00	0.01
Current Ratio	0.05	0.06	0.95	2.28	3.78	3.95
Quick Ratio	0.05	0.06	0.92	2.17	3.54	3.65
Interest Coverage	-2.04	-2.37	-11.64	-16.88	30.98	5.62

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	48.89	35.35	296.28	80.69	30.21	47.71
Asset Turnover	0.05	0.07	0.09	0.49	1.39	1.31
Receivable days	--	907.62	1,507.18	299.83	111.32	94.41
Inventory Days	--	74.81	90.63	40.66	30.12	30.18
Payable days	--	1,645.41	590.13	94.40	45.42	42.65
Cash Conversion Cycle	--	-662.98	1,007.68	246.09	96.03	81.94

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.